Results 161 to 170 of about 6,789 (241)

Hepatic angiosarcoma in a patient treated with obeticholic acid for primary biliary cholangitis. [PDF]

Hepatol Forum
Arif AA, Punnen S, Bleszynski M, Daniel R O, Yoshida EM.   +4 more
europepmc   +1 more source

Comparing the Efficacy and Safety of Obeticholic Acid and Semaglutide in Patients With Non-Alcoholic Fatty Liver Disease: A Systematic Review. [PDF]

Cureus, 2022
Ahmed NR, Kulkarni VV, Pokhrel S, Akram H, Abdelgadir A, Chatterjee A, Khan S.   +6 more
europepmc   +1 more source

Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world. [PDF]

JHEP Rep
Terracciani F, De Vincentis A, D'Amato D, Cristoferi L, Gerussi A, Invernizzi P, Scaravaglio M, Vanni E, Campion D, Morgando A, Valiani V, Boccaccio V, Morisco F, Surace L, Cavalli I, Delle Monache G, Salomone F, Ieluzzi D, Angrisani D, Tortora R, Cuffari B, Moretti A, Nardone G, Fagiuoli S, Viganò M, Vettori G, Cerini F, Gimignani G, Mattalia A, Pizzolante F, De Matthaeis N, Rigamonti C, Manfredi GF, Boano V, Begini P, Lleo A, Colapietro F, Plebani R, Alvaro D, Venere R, Degasperi E, Borghi M, Lampertico P, Giannini EG, Labanca S, Viganò R, D'Amico F, Castellaneta A, Squeo F, Cadamuro L, Capodicasa L, Marzioni M, Buzzanca V, Poggi G, Mussetto A, Cozzolongo R, Losito F, Bertino G, Russello M, Cannavò M, Scivetti P, Pompili M, Tortora A, Niro AG, Cotugno R, Pozzoni P, Riva A, Chessa L, Miglianti M, Cuccorese G, Pace Palitti V, Abenavoli L, Terreni N, Zolfino T, Morelli O, Saitta C, Casella S, Pellicelli A, Brunetto M, Coco B, Galli A, Marra F, Curto A, Floreani A, Cazzagon N, Rollo P, Bonaiuto E, Simone L, Muratori L, Rosina F, Distefano M, Capello E, Bellia V, Sacco R, Alagna G, Baiocchi L, Crocé LS, Ricci C, Poisa P, Izzi A, Boninsegna S, Calvaruso V, Carbone M, Vespasiani-Gentilucci U, “Italian PBC registry” and the “Club Epatologi Ospedalieri” PBC working group.   +104 more
europepmc   +1 more source

New developments in the treatment of primary biliary cholangitis – role of obeticholic acid

, 2017
Manan Jhaveri, Kris V. Kowdley
openalex   +2 more sources

Obeticholic acid ameliorates obesity and hepatic steatosis by activating brown fat. [PDF]

Exp Ther Med, 2021
Zhang H, Dong M, Liu X.
europepmc   +1 more source

EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS PREVIOUSLY TREATED WITH FIBRATES OR OBETICHOLIC ACID

A. Villamil, D. K. Pratt, Andreas E. Kremer, Vincenza Calvaruso, Elena Gómez Dominguez, Xin Qi, Sarah Proehl, William Barchuk, Timothy R. Watkins, Stuart C. Gordon   +9 more
openalex   +1 more source

Hepatoprotective effect of obeticholic acid on acetaminophen induced hepatotoxicity in mice

, 2022

openalex   +1 more source

Obeticholic Acid Decreases Intestinal Content of Enterococcus in Rats With Cirrhosis and Ascites. [PDF]

Hepatol Commun, 2021
Yan K, Hung A, Parmer C, Yang H, Jain D, Lim B, Goodman AL, Garcia-Tsao G.   +7 more
europepmc   +1 more source

Mechanisms Underlying the Protective Effects of Obeticholic Acid-activated FXR in Valproic Acid-induced Hepatotoxicity via Network Pharmacology, Molecular Docking and Molecular Dynamics Simulations [PDF]

Yanan Chen, Jingkai Zhou, Shansen Xu, Lei Wang   +3 more
openalex   +1 more source

Clinical and metabolic effects associated with weight changes and obeticholic acid in non‐alcoholic steatohepatitis [PDF]

, 2018
Bilal Hameed, Norah A. Terrault, Ryan M. Gill, Rohit Loomba, Naga Chalasani, Jay H. Hoofnagle, Mark L. Van Natta, for the NASH CRN   +7 more
openalex   +1 more source